Not Yet RecruitingNot Applicable

Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

Netherlands30 participantsStarted 2025-08-01

Plain-language summary

The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with a (supra)sellar tumor * Visual field loss based on the most recent SAP; False positive rate \<15%; fixation losses \<20% * Informed written consent Exclusion Criteria: * Neurological disorders * Eye disease not related to a (supra)sellar tumor

What they're measuring

Convert validity

Timeframe: Baseline

Test-retest reliability

Timeframe: baseline 1, baseline 2, 6-8 weeks post-operative

Trial details

NCT IDNCT06266949

SponsorUniversity Medical Center Groningen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-01

Contact for this trial

Jos MA Kuijlen, MD/PHD

050 361 2837 jmakuijlen@umcg.nl

View on ClinicalTrials.gov More Pituitary Tumor trials